Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population

Clinical and Vaccine Immunology

Volumn 14, Issue 1, 2007, Pages 85-86

  Miernyk, Karen M ^a,b   Bruden, Dana L ^b   Bruce, Michael G ^b   McMahon, Brian J ^a   Hennessy, Thomas W ^b   Peters, Helen V ^a   Hurlburt, Debby A ^b   Sacco, Frank ^c   Parkinson, Alan J ^b  

^a ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

AMERICAN INDIAN; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; ESKIMO; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; UREA BREATH TEST; BLOOD; IMMUNOLOGY; OUTCOME ASSESSMENT; UNITED STATES;

ALASKA; ANTIBODIES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INDIANS, NORTH AMERICAN; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 34247848059     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00253-06     Document Type: Article

References (10)

1. Cutler, A. F., V. M. Prasad, and P. Santogade. 1998. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am. J. Med. 105:18-20.
2. Evans, D. J., D. G. Evans, D. Y. Graham, and P. D. Klein. 1989. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 96:1004-1008.
3. Fallone, C. A., V. G. Loo, and A. N. Barkun. 1998. Utility of serology in determining Helicobacter pylori eradication after therapy. Can. J. Gastroenterol. 12:117-124.
4. Kato, M., Y. Yamaoka, J. J. Kim, R. Reddy, M. Asaka, K. Kashima, M. S. Osato, F. A. K. El-Zaatari, D. Y. Graham, and D. H. Kwon. 2000. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob. Agents Chemother. 44:2214-2216.
5. Kim, J. J., R. Reddy, M. Lee, J. G. Kim, F. A. K. El-Zaatari, M. S. Osato, D. Y. Graham, and D. H. Kwon. 2001. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J. Antimicrob. Chemother. 47:459-461.
6. Koizumi, W., S. Tanabe, H. Imaizumi, K. Hibi, M. Kida, M. Ohida, I. Okayasu, and K. Saigenji. 2003. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection. Hepatogastroenterology 50:293-296.
7. McMahon, B. J., M. G. Bruce, T. W. Hennessy, D. L. Bruden, F. Sacco, H. Peters, D. A. Hurlburt, J. M. Morris, A. L. Reasonover, G. Dailide, D. E. Berg, and A. J. Parkinson. 2006. Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment. Pharmacol. Ther. 23:1215-1223.
8. Perez-Perez, G. I., A. F. Cutler, and M. J. Blaser. 1997. Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin. Infect. Dis. 25:1038-1043.
9. Vasquez, A., Y. Valdez, R. H. Gilman, J. J. McDonald, T. U. Westblom, D. Berg, H. Mayta, and V. Gutierrez. 1996. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in miniwell format. J. Clin. Microbiol. 34:1232-1234.
10. Vikram, K., N. Anathakrishnan, and S. Badrinath. 2002. Chronological change in H. pylori antibody titers after treatment and its utility in follow-up. Am. J. Gastroenterol. 97:1563-1564.